|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Muñoz N, Bosch FX, de Sanjosé S, Herrero
R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ:
International Agency for Research on Cancer Multicenter Cervical
Cancer Study Group: Epidemiologic classification of human
papillomavirus types associated with cervical cancer. N Engl J Med.
348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakuragi N: Up-to-date management of lymph
node metastasis and the role of tailored lymphadenectomy in
cervical cancer. Int J Clin Oncol. 12:165–175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X, Wang HK, Li Y, Hafner M, Banerjee
NS, Tang S, Briskin D, Meyers C, Chow LT, Xie X, et al: microRNAs
are biomarkers of oncogenic human papillomavirus infections. Proc
Natl Acad Sci USA. 111:pp. 4262–4267. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsujiura M, Ichikawa D, Komatsu S,
Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi
K, Fujiwara H, et al: Circulating microRNAs in plasma of patients
with gastric cancers. Br J Cancer. 102:1174–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Heneghan HM, Miller N, Lowery AJ, Sweeney
KJ, Newell J and Kerin MJ: Circulating microRNAs as novel minimally
invasive biomarkers for breast cancer. Ann Surg. 251:499–505. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang R,
Yang XM, Li J, Zhang YL, Wang YH, Ma MZ, et al: miR-506 acts as a
tumor suppressor by directly targeting the hedgehog pathway
transcription factor Gli3 in human cervical cancer. Oncogene.
34:717–725. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY,
Lu WG and Xie X: Reduced miR-100 expression in cervical cancer and
precursors and its carcinogenic effect through targeting PLK1
protein. Eur J Cancer. 47:2166–2174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F,
Xie X, Zhou C and Lu W: Suppressed miR-424 expression via
upregulation of target gene Chk1 contributes to the progression of
cervical cancer. Oncogene. 32:976–987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haller M, Hock AK, Giampazolias E, Oberst
A, Green DR, Debnath J, Ryan KM, Vousden KH and Tait SW:
Ubiquitination and proteasomal degradation of ATG12 regulates its
proapoptotic activity. Autophagy. 10:2269–2278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murrow L, Malhotra R and Debnath J:
ATG12-ATG3 interacts with Alix to promote basal autophagic flux and
late endosome function. Nat Cell Biol. 17:300–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li ZZ, Shen LF, Li YY, Chen P and Chen LZ:
Clinical utility of microRNA-378 as early diagnostic biomarker of
human cancers: A meta-analysis of diagnostic test. Oncotarget.
7:58569–58578. 2016.PubMed/NCBI
|
|
15
|
Deng H, Guo Y, Song H, Xiao B, Sun W, Liu
Z, Yu X, Xia T, Cui L and Guo J: MicroRNA-195 and microRNA-378
mediate tumor growth suppression by epigenetical regulation in
gastric cancer. Gene. 518:351–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zanutto S, Pizzamiglio S, Ghilotti M,
Bertan C, Ravagnani F, Perrone F, Leo E, Pilotti S, Verderio P,
Gariboldi M and Pierotti MA: Circulating miR-378 in plasma: A
reliable, haemolysis-independent biomarker for colorectal cancer.
Br J Cancer. 110:1001–1007. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li B, Wang Y, Li S, He H, Sun F, Wang C,
Lu Y, Wang X and Tao B: Decreased expression of miR-378 correlates
with tumor invasiveness and poor prognosis of patients with glioma.
Int J Clin Exp Pathol. 8:7016–7021. 2015.PubMed/NCBI
|
|
18
|
Lee DY, Deng Z, Wang CH and Yang BB:
MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis
by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA.
104:pp. 20350–20355. 2007; View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma J, Lin J, Qian J, Qian W, Yin J, Yang
B, Tang Q, Chen X, Wen X, Guo H and Deng Z: MiR-378 promotes the
migration of liver cancer cells by down-regulating Fus expression.
Cell Physiol Biochem. 34:2266–2274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu BL, Peng XH, Zhao FP, Liu X, Lu J, Wang
L, Li G, Chen HH and Li XP: MicroRNA-378 functions as an onco-miR
in nasopharyngeal carcinoma by repressing TOB2 expression. Int J
Oncol. 44:1215–1222. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fedorko M, Stanik M, Iliev R,
Redova-Lojova M, Machackova T, Svoboda M, Pacik D, Dolezel J and
Slaby O: Combination of MiR-378 and MiR-210 serum levels enables
sensitive detection of renal cell carcinoma. Int J Mol Sci.
16:23382–23389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dang CV: c-Myc target genes involved in
cell growth, apoptosis, and metabolism. Mol Cell Biol. 19:1–11.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Metlagel Z, Otomo C, Takaesu G and Otomo
T: Structural basis of ATG3 recognition by the autophagic
ubiquitin-like protein ATG12. Proc Natl Acad Sci USA. 110:pp.
18844–18849. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rubinstein AD, Eisenstein M, Ber Y, Bialik
S and Kimchi A: The autophagy protein Atg12 associates with
antiapoptotic Bcl-2 family members to promote mitochondrial
apoptosis. Mol Cell. 44:698–709. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cordani M, Oppici E, Dando I, Butturini E,
Dalla Pozza E, Nadal-Serrano M, Oliver J, Roca P, Mariotto S,
Cellini B, et al: Mutant p53 proteins counteract autophagic
mechanism sensitizing cancer cells to mTOR inhibition. Mol Oncol.
10:1008–1029. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan B, Feng B, Chen Y, Huang G, Wang R,
Chen L and Song H: MiR-200b regulates autophagy associated with
chemoresistance in human lung adenocarcinoma. Oncotarget.
6:32805–32820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feng M, Li Z, Aau M, Wong CH, Yang X and
Yu Q: Myc/miR-378/TOB2/cyclin D1 functional module regulates
oncogenic transformation. Oncogene. 30:2242–2251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Feakins RM, Nickols CD, Bidd H and Walton
SJ: Abnormal expression of pRb, p16, and cyclin D1 in gastric
adenocarcinoma and its lymph node metastases: Relationship with
pathological features and survival. Hum Pathol. 34:1276–1282. 2003.
View Article : Google Scholar : PubMed/NCBI
|
